Review 2026 (Springer Inflammopharmacology, DOI 10.1007/s10787-025-01882-z) confirmed its cytoprotective effect on the digestive tract with oral doses ranging from 10 to 50 g/kg
Research indicates it reduces pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta, without broadly suppressing immune function the way corticosteroids do
In clinical trials, there were 7 reported cases of papillary thyroid carcinoma in patients treated with liraglutide and 1 case in a comparator-treated patient (1.5 vs
Patients who are pregnant, nursing, or have certain conditions (such as pancreatitis, gallbladder disease, or thyroid cancer) may not be eligible
Contents: 500mg/2ml (250mg per ml) Sterile water Appearance Sterile clear pale yellow to yellow solution Storage Store below 25C / 77F, Keep in tight container, Protect from light
ISBN 978-0-8385-1301-9